4//SEC Filing
Llana Ted 4
Accession 0001441848-10-000021
CIK 0001441848other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 1:42 PM ET
Size
10.9 KB
Accession
0001441848-10-000021
Insider Transaction Report
Form 4
Llana Ted
SVP, Commercial and Corp Dev
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2010-04-21$27.00/sh−64,000$1,728,000→ 0 totalExercise: $6.17Exp: 2016-01-23→ Common Stock (64,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-04-21$27.00/sh−26,693$720,711→ 0 totalExercise: $9.95Exp: 2016-08-06→ Common Stock (26,693 underlying) - Disposition to Issuer
Comon Stock
2010-04-21$27.00/sh−39,893$1,077,111→ 0 total
Footnotes (3)
- [F1]This stock option was canceled and exchanged for a cash payment of $1,333,120.00 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.
- [F2]This stock option was canceled and exchanged for a cash payment of $455,115.65 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.
- [F3]This stock option was canceled and exchanged for a cash payment of $455,115.65 in accordance with the Agreement and Plan of Merger, dated March 9, 2010, among the issuer, Amber Acquisition Inc. and Abbott Laboratories in connection with the merger of Amber Acquisition Inc. with and into the issuer. The cash payment made with respect to this stock option equals the product of (x) the number of option shares canceled multiplied by (y) the difference between the merger consideration ($27 per share) and the exercise price for this stock option.
Documents
Issuer
FACET BIOTECH CORP
CIK 0001441848
Entity typeother
Related Parties
1- filerCIK 0001453531
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 1:42 PM ET
- Size
- 10.9 KB